Multiple Sclerosis

How Can Stem Cells Treat Multiple Sclerosis?

Stem Cell Treatment Offers New Hope to Patients With Multiple sclerosis

 

Multiple sclerosis can cause numerous symptoms, including pain, weakness, and loss of sensitivity, among others. The severity of these complications can vary, but for most patients, symptoms get more severe over time. As the disease progresses, many patients experience loss of coordinated movement, difficulty with speech, and decreased vision.

Other symptoms may be less obvious. Patients may have bladder or bowel control problems, increased susceptibility to urinary tract infections, ongoing fatigue, and decrease in bone density. Severe cases can even cause paralysis.

 

See if stem cell treatment is right for you.

Stem Cell Therapy Can Help:

  • Reduce pain and inflammation
  • Slow progression of muscle weakness
  • Increase muscle tone
  • Restore sensation
  • Reduce muscle spasms
  • Improve strength, balance, and coordination
  • Improve quality of life

Transform Your Life with Advanced Stem Cell Therapy.

Our medical and scientific teams continues research to improve therapies and offer additional treatment options. Contact a CKM Patient Advocate to see if new treatments are available for your condition.

World Leader in Stem Cell Therapy

Advanced stem cell therapy offers new hope to some patients frustrated by current treatments for conditions that can be difficult to treat or that may provide only temporary relief. At CKM Stem Cell, our therapies and protocols take advantage of the body’s natural healing process to help:

  • Promote cellular regeneration of damaged tissue
  • Enhance immunity and optimize health
  • Boost overall energy throughout your body
  • Improve your overall quality of life

Advanced Treatment Options—New Hope for MS Patients

Discover how stem cell therapy has helped many patients with multiple sclerosis enjoy more mobility and energy—and reduce chronic pain and anxiety in their lives.

Citations and Scientific References

Our medical team takes pride in our reputation for collaborating with other scientists worldwide on research studies and of established scientific publications. Review these published studies that support the science of our treatment protocols.

VIEW CITATIONS
  • Meng, M., Liu, Y., Wang, W., Wei, C., Liu, F., Du, Z., Xie, Y., Tang, W., Hou, Z., & Li, Q. (2018). Umbilical cord mesenchymal stem cell transplantation in the treatment of multiple sclerosis. American journal of translational research, 10(1), 212–223. Available from: Umbilical cord mesenchymal stem cell transplantation in the treatment of multiple sclerosis (nih.gov)
  • He Jialin, Huang Yan, Liu Jianyang, Lan Ziwei, Tang Xiangqi, Hu Zhiping. (2021) The Efficacy of Mesenchymal Stem Cell Therapies in Rodent Models of Multiple Sclerosis: An Updated Systematic Review and Meta-Analysis. Frontiers in Immunology. 12; 2021 Available from: https://doi.org10.3389/fimmu.2021.711362
  • Mansoor SR, Zabihi E, Ghasemi-Kasman M. The potential use of mesenchymal stem cells for the treatment of multiple sclerosis. Life Sci. 2019 Oct 15;235:116830. Available from: https://doi.org/10.1016/j.lfs.2019.116830
  • Li, Jin-Feng, et al. “The Potential of Human Umbilical Cord-Derived Mesenchymal Stem Cells as a Novel Cellular Therapy for Multiple Sclerosis.” Cell Transplantation, Jan. 2014, pp. 113–122, Available from: https://doi.org/10.3727/096368914X685005
  • Gugliandolo, A., Bramanti, P., & Mazzon, E. (2020). Mesenchymal Stem Cells in Multiple Sclerosis: Recent Evidence from Pre-Clinical to Clinical Studies. International journal of molecular sciences, 21(22), 8662. Available from: https://doi.org/10.3390/ijms21228662
  • Xiao J, Yang R, Biswas S, Qin X, Zhang M, Deng W. Mesenchymal Stem Cells and Induced Pluripotent Stem Cells as Therapies for Multiple Sclerosis. International Journal of Molecular Sciences. 2015; 16(5):9283-9302. Available from: https://doi.org/10.3390/ijms16059283
  • Riordan, N. H., Morales, I., Fernández, G., Allen, N., Fearnot, N. E., Leckrone, M. E., Markovich, D. J., Mansfield, D., Avila, D., Patel, A. N., Kesari, S., & Paz Rodriguez, J. (2018). Clinical feasibility of umbilical cord tissue-derived mesenchymal stem cells in the treatment of multiple sclerosis. Journal of translational medicine, 16(1), 57. Available from: https://doi.org/10.1186/s12967-018-1433-7

Keep hope alive. Book a call with one of our experts to discover if stem cell therapy could be the right solution for your child.

Signature Cells

Proprietary protocols. Based on advanced science.

The most effective stem cell therapy starts with the best possible cells. CKM Signature Cells are produced from mesenchymal stem cells (MSCs) derived from Wharton’s jelly umbilical cord tissue.

Then, based on our proprietary protocols, these cells are cultured and expanded in our on-site lab—and tested to make sure they meet high standards for purity and potency and demonstrate:

  • High levels of anti-inflammatory properties

  • Best potential to modulate the immune system

  • More potential to stimulate healing

Discover how Signature Cells and our advanced treatment protocols can potentially start the path to a brighter future for your child and your family.

Focused on Patient Outcomes

Learn how a personalized treatment program designed in consultation with our experts can potentially help:

  • Promote healing of damaged tissue
  • Modulate the immune system
  • Boost energy
  • Enhance mobility, strength, and balance
  • Restore sensation
  • Enhance mood
  • Reduce spasms

Real People. Real Results.

Meet patients who now enjoy better health, more energy, less pain, and get more out of life thanks to advanced stem cell therapy for multiple sclerosis.

Molly

CKM Patient

My balance and coordination have improved. I’m running into walls less often, so that’s good. My MRI showed that the damage has not progressed.